EUVIMEDEUVIMED entdecken
Open Access

Predicting prognosis and immune status in sarcomas by identifying necroptosis-related lncRNAs

Zhen Wang, Anfang He, Zhengyu Lu, Wenli Xu, Gang Wu, Tingsheng Peng

Aging · 2024

DOI: 10.18632/aging.205383 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Zhen Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, Guangdong, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Osteosarcoma, Bone Neoplasms. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Sarcomas are a type of highly heterogeneous malignant tumors originating from mesenchymal tissues. Necroptosis is intricately connected to the oncogenesis and progression of tumors. The main goal of this research is to assess the prognostic value of necroptosis-related lncRNAs (NRlncRNAs) in sarcomas and to develop a risk model based on NRlncRNAs to evaluate prognostic and immune status of the sarcomas. METHODS: We screened NRlncRNAs using the gene co-expression network, developed a prognostic risk model of sarcomas, and then verified the model. Following that, various bioinformatics analysis algorithms were employed to analyze the distinct characteristics of patients of the risk model. Furthermore, the function and regulatory mechanism of NRlncRNA SNHG6 in sarcomas were investigated through osteosarcoma cell experiments, such as qRT-PCR, Western blot, CCK-8, clone formation, and transwell assay. RESULTS: We successfully developed a NRlncRNAs-related prognostic risk model and screened 5 prognosis-related NRlncRNAs, with SNGH6 being the most significant for prognosis of patients. According to results, the significant differences exist in prognosis, clinical characteristics, and tumor immune status among patients of the risk model. The experiments of osteosarcoma cells demonstrated that NRlncRNA SNHG6 knockdown significantly attenuated the cells' proliferation, migration, and invasion. qRT-PCR and WB results showed that SNHG6 regulated AXL and AKT signaling. CONCLUSIONS: We have developed an innovative investigation on NRlncRNAs, which can serve as a reference for diagnosis, therapy, and prognosis of sarcomas. Additionally, we demonstrated that NRlncRNA SNHG6 regulated AXL and AKT signaling in osteosarcoma cells and the proliferation, migration, and invasion of tumor cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingOsteosarcomaBone NeoplasmsHumansCell Line, TumorProto-Oncogene Proteins c-aktNecroptosisPrognosisGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

SNHG6TMEnecroptosisrisk modelsarcomas

Substanzen

RNA, Long NoncodingProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Pathology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, Guangdong, China.

Zitieren

APA

Wang, Z., He, A., Lu, Z., Xu, W., Wu, G., & Peng, T. (2024). Predicting prognosis and immune status in sarcomas by identifying necroptosis-related lncRNAs. Aging. https://doi.org/10.18632/aging.205383

Vancouver

Wang Z, He A, Lu Z, Xu W, Wu G, Peng T. Predicting prognosis and immune status in sarcomas by identifying necroptosis-related lncRNAs. Aging. 2024. doi:10.18632/aging.205383

BibTeX
@article{Wang2024,
  author = {Wang, Zhen and He, Anfang and Lu, Zhengyu and Xu, Wenli and Wu, Gang and Peng, Tingsheng},
  title = {Predicting prognosis and immune status in sarcomas by identifying necroptosis-related lncRNAs},
  journal = {Aging},
  year = {2024},
  doi = {10.18632/aging.205383}
}
Kostenlos starten →